Earnings

Solara Active Pharma Sciences reports consolidated net loss of Rs 13.46 crore in the June 2024 quarter

Solara Active Pharma Sciences closes its rights issue for raising Rs 449.95 cr

The pharma company also told exchanges that Aditya Puri has resigned as the chairman and non-executive director

Solara Active Pharma Sciences gain on USFDA all-clear for Cuddalore unit

Solara Active Pharma Science plans to issue equity shares with a face value of Rs 10 each, totalling up to Rs 450 crore, including premium

Solara Active Pharma Science gains on board nod to raising up to Rs 450 crore

The stock saw a sharp upmove of 300 percent between March 2020 and July 2021, touching Rs 1,800 as COVID outbreak led to a spike in demand for its main offerings — Ibuprofen, Favipiravir and Gabapentin

Solara Active Pharma spurts 9% on heavy volumes

SOLARA ACTIVE P Standalone March 2023 Net Sales at Rs 380.62 crore, up 5.49% Y-o-Y

Buzzing stocks: Adani Enterprises, ONGC, Apollo Hospitals, CESC, Eicher, Grasim, GMR AIrport, NBCC India, FDC, Man Industries, Solara Active Pharma, Coforge

Stocks that will see action on February 14, 2023

The agency, with its designated investigator, inspected the facility from 23rd to 26th January 2023.

Solara Active Pharma says USFDA concludes inspection at Vizag facility

SOLARA ACTIVE P Consolidated December 2022 Net Sales at Rs 394.75 crore, up 293.41% Y-o-Y

Media reports suggest that there is shortage of Ibuprofen and paracetamol in China due to rising Covid-19 cases and the demand for medicines is expected to rise. However, the prices have not moved up yet globally for Ibuprofen. IOL Chemical & Pharma is the largest producer of Ibuprofen with ~35% Global share and commenced paracetamol production in April 2022. Solara Active Pharma's-Vizag facility received European approval to manufacture Ibuprofen.Granules India has world's largest Paracetamol API facility. Analysts say companies don't have permission to sell in China and even the raw material comes from China, which could adversely affect the afore-mentioned companies.
Subscribe To ET Now For Latest Updates On Stocks, Business News, Trading | https://bit.ly/SubscribeToETNow

To Stay Updated Download the Times Now App :-
Android Google Play :  https://goo.gl/zJhWjC
Apple App Store :  https://goo.gl/d7QBQZ

Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com

Subscribe Now To Our Network Channels:-
Times Now: https://bit.ly/SubscribeToTimesNow
Mirror Now: https://bit.ly/SubscribeToMirrorNow

Pushed via Slike

Why Has IOL Chemical Pharma And Solara Active Pharma Risen Up To 15% In Day's Trade?

Indian Overseas Bank, UCO Bank, Solara Active Pharma Sciences Ltd and Central Bank of India are among the other gainers in the BSE’s ‘A’ group today, 21 December 2022.

IOL Chemicals & Pharmaceuticals Ltd leads gainers in ‘A’ group

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

SSL Pharma Sciences is a manufacturer of pharmaceutical preparation